Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
JAMA ; 266(20): 2852-5, 1991 Nov 27.
Artigo em Inglês | MEDLINE | ID: mdl-1834870

RESUMO

STUDY OBJECTIVE: To evaluate the risk and associated cofactors for hepatitis B infection in inner-city pregnant women not registered for prenatal care. DESIGN: Fifteen-month survey of 208 patients not registered for prenatal care, compared with 1555 women registered for prenatal care during the same period. SETTING: An urban university hospital prenatal clinic and labor unit. RESULTS: Unregistered patients had a significantly higher rate of hepatitis B surface antigen positivity than patients who had registered with the clinic (6.7% vs 0.8%; P less than .0001). Unregistered patients with positive results of urine drug screening (46%) had a relative risk for seropositivity of 29.2%, compared with registered patients who did not have histories of illicit drug use (95% confidence interval, 25.9% to 32.4%), while registered patients with past histories of drug use had a relative risk of 6.7%, compared with the reference group that did not have histories of drug use (95% confidence interval, 1.8% to 24.0%). CONCLUSIONS: Among inner-city pregnant women not registered for prenatal care, a positive result of urine drug screening is a rapidly available marker for increased risk of hepatitis B surface antigen positivity. Infants born to unregistered women with positive results of urine drug screening before maternal hepatitis B surface antigen results are available may warrant empiric initiation of hepatitis B virus-specific prophylaxis.


Assuntos
Hepatite B/epidemiologia , Complicações Infecciosas na Gravidez/epidemiologia , Cuidado Pré-Natal/estatística & dados numéricos , Feminino , Hepatite B/etnologia , Hepatite B/imunologia , Hepatite B/prevenção & controle , Antígenos de Superfície da Hepatite B/análise , Vacinas contra Hepatite B , Humanos , Philadelphia/epidemiologia , Gravidez , Complicações Infecciosas na Gravidez/etnologia , Complicações Infecciosas na Gravidez/prevenção & controle , Fatores de Risco , Vacinas Sintéticas , Vacinas contra Hepatite Viral
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA